Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_assertion type Assertion NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_head.
- NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_assertion description "[We speculate that CYP1B1 inhibition in endometrial carcinomas could be a useful therapeutic approach as it regulates several potential anticancer targets like cyclin E1, Skp2, and TRAIL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_provenance.
- NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_assertion evidence source_evidence_literature NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_provenance.
- NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_assertion SIO_000772 19690133 NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_provenance.
- NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_assertion wasDerivedFrom befree-2016 NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_provenance.
- NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_assertion wasGeneratedBy ECO_0000203 NP758246.RAznbDxku3TILLR2K_e7TePnQuE9BBZDA_b3Ic31DMFE0130_provenance.